Arrayit Corporation (OTC: ARYC) CEO Dr. Mark Schena, PhD, discussed the company’s prospects in an interview with ListonStreetPulse.com’s Chief Editor Shas. Dr. Schena noted in the interview that the market outlook for the company’s core intellectual property is exceptional. Dr. Schena also discussed about ARYC’s ongoing research and development efforts during the interview. Arrayit has already made significant progress on the operating front. Earlier this year, the company signed an exclusive distributorship agreement with DHK Medical Products for genome testing in India.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
